
New Medicare rules could make 3.6 million Americans — or even more — eligible for treatment with the pricey weight-loss drug Wegovy, a new study finds. Under the new rules, the government will pay for Wegovy treatment if a person with high BMI also has heart disease. Until now, federal regulations have restricted Medicare from… read on > read on >